STOCK ACQUISITION AGREEMENT
This
Stock Acquisition Agreement (this "Agreement") is entered into on July31, 2006,
by and between the sellers listed on Schedule
“A”
and
signatory hereto (collectively, the “Sellers” and each a “Seller”) and Adera
Mines Limited, a Nevada corporation (the “Company”)
with
respect to the following:
A. Sellers
own collectively one hundred percent (100%) of the issued and outstanding common
stock of Chatsworth Data Corporation, a California corporation (“CDC”);
B. The
Company desires to purchase all of the common stock, no par value, of CDC owned
by the Sellers (the “CDC Stock”) and to operate CDC as a wholly owned subsidiary
(the “CDC Subsidiary”); and
C. The
Company will purchase and the Sellers will sell the CDC Stock on the terms
and
conditions set forth herein.
NOW,
THEREFORE, in consideration of the premises and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged,
the
parties agree as follows (certain definitions of capitalized terms are set
forth
in Schedule
“B”):
ARTICLE
I
PURCHASE
AND SALE
1.1 Purchase
and Sale of CDC Stock.
Subject
to the terms and conditions contained herein, simultaneously with the execution
of this Agreement, each Seller hereby conveys, transfers, assigns and delivers
to the Company good and valid title to the CDC Stock, free and clear of any
Liens. In full payment of the purchase price for the CDC Stock, the Company
is
hereby delivering (i) a wire transfer to each Sellers in the amounts set forth
on Schedule
“A”
hereto
totaling an aggregate amount of five million dollars ($5,000,000), (ii) 250,000
shares of common stock of the Company (the “Shares”) and (iii) a promissory note
executed by the Company, and payable to each Seller in the amounts set forth
on
Schedule
“A”
hereto
totaling an aggregate principal amount of $2,000,000 in the form of that
attached hereto as Schedule
“C” hereto
(the “Notes”). At
the
Closing, Sellers shall deliver to the Company written resignations of all of
the
directors and officers of CDC, and representatives of the Company will be
elected as the sole directors and officers of CDC after the Closing. Sellers
shall also deliver to the Company all of the certificates representing the
CDC
Stock, endorsed in favor of the Company, and duly executed by each Seller and
each such Seller’s spouse, as required by law.
ARTICLE
II
REPRESENTATIONS
AND WARRANTIES OF EACH SELLER
Each
Seller represents and warrants to the Company and (except as disclosed in this
Agreement, including the schedules) that each of the following statements is
true and correct:
2.1 Ownership
of CDC Stock.
The
Sellers collectively own all of the outstanding equity of the Company and each
has the full right and authority to transfer the CDC Stock owned by such Seller
as set forth on Schedule B hereto. The CDC Stock is owned by each Seller free
and clear of any claims or Liens.
2.2 CDC
Financial Statements.
The
financial statements of CDC for the two year period ended December 2005, and
for
the three month period ended March 31, 2006, fairly and accurately present
the
Company’s asset and liabilities, financial results and overall financial
condition.
2.3 No
Adverse Changes.
Other
than as set forth on Schedule
2.3
attached
hereto or as is generally known to the Sellers, since March 31, 2006, there
has
been no material adverse change in the financial condition, results of
operations, cash flow, customer base, expense rates, regulatory environment,
competitive environment, intellectual property or prospects of CDC or its
business, and CDC has operated its business in the ordinary course of business.
No Seller knows of any reason that any such materially adverse change should
reasonably be expected in the future.
2.4 No
Claims; ERISA.
Other
than as set forth on Schedule
2.4
attached
hereto and incorporated herein by this reference, there are no claims or
litigation, pending or threatened against or affecting CDC or its business
or
properties. CDC has no benefit plans that would qualify or be subject to the
federal laws of “ERISA.”
2.5 Ownership
of CDC Assets.
Other
than as set forth on Schedule
2.5
attached
hereto and incorporated herein by this reference, CDC is the lawful owner,
with
good and marketable title, of the assets used in its business, including all
patents, trademarks, trade secrets, proprietary information, formulae, trade
formulae and other intellectual property (the “Intellectual Property”), free and
clear of any Liens, all of which tangible assets are in good working condition,
reasonable wear and tear excepted, and all of which intangible assets CDC has
the right to use. All of the Intellectual Property is owned or licensed by
CDC,
and CDC has the right to use, license and exploit such property, and Sellers
know of no reason why such Intellectual Property would infringe upon the rights
of any other persons.
2.6 Compliance
with Permits and Regulations; Good Standing.
Except
as otherwise set forth on Schedule
2.6
attached
hereto and incorporated herein by this reference, CDC has substantially complied
with, and is not in substantial default under or in substantial violation of,
any permit, rule, regulation or order to which CDC or its business are subject.
CDC is a corporation in good standing under the laws of the State of California.
CDC is qualified as a foreign corporation in every state where it is required
to
do so, or where the failure to do so, would have a material effect on CDC or
its
business. CDC and its directors have taken no action to dissolve CDC or assign
its assets for the benefit of any creditors.
2.7 Taxes.
CDC and
each Seller have filed all returns and paid all taxes due by them.
2
2.8 Competing
Ventures.
Except
as disclosed in Section
4.1,
no
Seller owns, directly or indirectly, any interest in a corporation, partnership,
firm or association, which is either a competitor, potential competitor,
customer or supplier of CDC or has an existing contractual relationship with
CDC.
2.9 Full
Disclosure.
This
Agreement, the financial statements and the other information delivered
to the
Company and its investors, brokers, representatives and agents with respect
to
CDC do not (a) contain any untrue statement of a material fact regarding CDC
or
its business or (b) omit to state a material fact necessary to make the
statements regarding CDC or its business contained herein and therein not
misleading.
ARTICLE
III
REPRESENTATIONS
AND WARRANTIES OF THE COMPANY
The
Company represents and warrants to Sellers and (except as disclosed in this
Agreement, including the schedules) that each of the following statements is
true and correct:
3.1 Existence
and Good Standing. The
Company is a corporation in good standing under the laws of the state of Nevada.
The Company will own and operate CDC as a wholly owned subsidiary on and after
the Closing. The Company has full power and authority to enter into and perform
this Agreement and to deliver the cash purchase price and the Note. Each of
the
Note and this Agreement is the valid and binding obligation of the Company
enforceable in accordance with its respective terms.
ARTICLE
IV
ADDITIONAL
AGREEMENTS; CLOSING CONDITIONS
4.1 Company
Obligations for Closing. On
the
Closing, the Company shall deliver to Sellers each of the following: (i) the
Note in the amounts set forth in Schedule
“A”,
(ii)
the aggregate cash purchase price of Five Million Dollars ($5,000,000), as
delivered by wire in the amounts and to the accounts or payees designated by
Sellers on Schedule
“A”,
(iii)
copies of the actions taken by the Board of Directors of the Company to approve
this Agreement and the issuance of the Shares in the amounts set forth in
Schedule
“A”
, and
(iv) a certificate of Good Standing from the State of Nevada, dated within
a
reasonable time prior to the Closing. In addition, it shall be a condition
to
the Closing that the Company shall have completed a financing in the amount
of
$6,000,000 immediately prior to, or simultaneously with, the
Closing.
4.2 Sellers’
Obligations for Closing.
On
the
Closing, Sellers shall deliver to the Company each of the following: (i) all
certificates of CDC Stock, representing 100% of the issued and outstanding
capital stock of CDC, (ii) the written resignation of all officers and directors
of CDC effective as of the Closing, and (iii) the audited financial statements
of CDC for the years ended 2004 and 2005, and the quarterly, reviewed, financial
statements for the quarter ended March 31, 2006, together with the report of
the
independent auditor for such financial statements.
3
4.3 Further
Obligations - Payment of Tax Obligations.
In
addition to, and without limitation of the foregoing, the parties hereto agree
and acknowledge that CDC is a “subchapter S” corporation for federal tax
purposes and accordingly, the Sellers may have certain tax payment obligations
for the period January 1, 2006 to the Closing (the “2006 Tax Period”). Upon
completion of the financial statements of the 2006 Tax Period and the generation
of the shareholders’ K-1 statements, the Sellers shall present copies of these
statements to the Company. The Company shall reimburse each Seller 44% of the
K-1 amount within 60 days of the presentation date of the K-1 to the Company.
4.4 Further
Assurances.
In
addition to each and every other provision of this Agreement, each party shall
execute such further documents and writings and take such further actions as
may
be or become necessary or desirable to carry out the provisions of this
Agreement or the Note and the transactions contemplated by this Agreement or
the
Note.
4.5 Indemnification.
4.5.1 General.
Each
party hereto will indemnify each other party for any losses, damages or expenses
arising from, related to or resulting from any breach (or third party claim
of
breach) of any representation, warranty or covenant in this Agreement.
4.5.2 Procedure.
Promptly upon receipt by an Indemnified Party of a notice of a claim by a third
party that may give rise to a claim under this Section, the Indemnified Party
shall give written notice thereof to the Indemnifying Party, although failure
to
do so shall not affect the right to indemnification except to the extent of
actual prejudice. The Indemnified Party shall allow the Indemnifying Party
to
assume control of the defense of any such action brought by a third party
provided that (i) the Indemnifying Party delivers to the Indemnified Party
an
agreement in writing to defend such claim at its sole cost and expense within
five (5) business days of notice from Indemnified Party, (ii) the Indemnifying
Party is financially capable for providing indemnification for such claim,
and
(iii) the defense will be conducted by reputable attorneys reasonably approved
by the Indemnified Party (retained by the Indemnifying Party at the Indemnifying
Party's sole cost and expense). The Indemnified Party will have the right to
participate in such proceedings and to be separately represented by attorneys
of
its own choosing at its own cost unless the interests of the Indemnified Party
and the Indemnifying Party in the action conflict in such a manner and to such
an extent as to require, consistent with applicable standards of professional
responsibility, the retention of separate counsel for the Indemnified Party,
in
which case the Indemnifying Party will pay for one separate counsel chosen
by
the Indemnified Party.
4.5.3 Limits
on Settlement.
The
Indemnifying Party may contest or settle such claim on such terms as the
Indemnifying Party may choose, provided
that
the
Indemnifying Party will not have the right, without the Indemnified Party's
written consent, to settle any such claim if such settlement (i) arises
from or is part of any criminal action, suit or proceeding, (ii) contains a
stipulation to, confession of judgment with respect to, or admission or
acknowledgement of, any liability or wrongdoing on the part of the Indemnified
Party, (iii) relates to any federal, state or local tax matters, or
(iv) provides for injunctive relief, or other relief other than damages,
which is binding on the Indemnified Party.
4
4.5.4 Separate
Indemnity Under Lease in Favor of Certain Sellers. In
addition to, and without limitation of the foregoing, the parties hereto agree
and acknowledge that the Company shall indemnify and hold harmless the
individual Sellers who are personal guarantors of the operating lease for CDC’s
headquarters and operating facility located at 00000 Xxxxxxx Xxxxxx, Xxxxxxxxxx,
Xxxxxxxxxx for any claims, damages or losses incurred by a Seller due to the
Company’s breach of any term or condition of the lease after the Closing. In the
event the Company shall renew or extend the lease, including the option to
extend the lease by one year, the Company shall use its best efforts to
eliminate the Sellers as guarantors thereunder.
ARTICLE
V
MISCELLANEOUS
5.1 Complete
Agreement; Modifications.
This
Agreement (including the Schedules and Exhibits hereto) constitutes the parties'
entire agreement with respect to the subject matter hereof and supersedes all
prior or contemporaneous agreements, representations, warranties, statements,
promises and understandings, whether oral or written, with respect to the
subject matter hereof. This Agreement may not be amended, altered or modified
except by a writing signed by the parties.
5.2 Notices.
Unless
otherwise specifically permitted by this Agreement, all notices under this
Agreement shall be in writing and shall be delivered by personal service,
telecopy, federal express or comparable overnight service or certified mail
(if
such service is not available, then by first class mail), postage prepaid,
to
such address as may be designated from time to time by the relevant party,
and
which shall initially be:
(i)
If to the Company:
|
(ii)
If to Sellers:
|
ADEREA
MINES LIMITED
00000
Xxxxxx Xxxxxx
Xxxxxxxxxx,
XX 00000
Tel:
000-000-0000
Fax:
000-000-0000
With
a copy to:
Xxxxxxxxxx
& Xxxxx LLP
00000
Xxxxxxxx Xxxxxxxxx, Xxxxx 000
Xxx
Xxxxxxx, XX 00000
Tel:
000-000-0000
Fax:
000-000-0000
Attention:
Xxxxxxxx X. Post, Esq.
|
To
the Persons and Addresses set forth on Schedule A hereto,
|
Any
notice sent by certified mail shall be deemed to have been given three (3)
business days after the date on which it is mailed. All other notices shall
be
deemed given when received. No objection may be made to the manner of delivery
of any notice actually received in writing by an authorized agent of a
party.
5
5.3 No
Assignment.
This
Agreement is not assignable by either party absent prior written consent of
the
other party. This Agreement shall be binding upon and inure to the benefit
of
the parties, their respective successors and permitted assigns. There are no
third party beneficiaries to this Agreement and nothing in this Agreement will
be construed to increase or alter the rights of any third party.
5.4 Governing
Law.
This
Agreement has been negotiated and entered into in the State of California,
concerns a California business and all questions with respect to this Agreement
and the rights and liabilities of the parties will be governed by the laws
of
California, regardless of the choice of laws provisions of California or any
other jurisdiction.
5.5 Arbitration.
Except
for actions seeking injunctive relief, which may be brought before any court
having jurisdiction, any disputes among the Company and the Sellers, which
are
not settled by agreement between the parties, shall be settled by arbitration
in
Los Angeles, California, in accordance with the Commercial Arbitration Rules
of
the American Arbitration Association then in effect. The arbitration provisions
will be the exclusive remedy of the parties except for injunctive relief. The
prevailing party in any dispute will pay the other party’s reasonable attorney’s
fees in connection with the arbitration.
5.6 Expenses.
Each
party shall bear its own fees and expenses incident to this Agreement and the
transactions contemplated by this Agreement, including attorneys' fees and
costs, and shall indemnify the other party from any Losses as a result of such
fees and expenses. However, any party shall be entitled to recover any
reasonable costs, including attorneys' fees, expended in enforcing this
Agreement.
5.7 Severability.
If any
part, term or provision of this Agreement is held by a court to be invalid,
illegal, unenforceable or otherwise in conflict with law, it shall be
inoperative and void, but the validity of the remaining parts, terms or
provisions shall not be affected and the rights and obligations of the parties
shall be construed and enforced as if this Agreement did not contain the
particular part, term or provision held to be invalid.
5.8 Counterparts.
This
Agreement may be executed in two or more counterparts, each of which shall
be
deemed an original but all of which together shall constitute one and the same
instrument.
REMAINDER
OF PAGE INTENTIONALLY BLANK
6
IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first
above written.
COUNTER
PART SIGNATURE PAGE TO STOCK ACQUISITION AGREEMENT
COMPANY:
ADERA
MINES LIMITED
By:
________________________________________
Name:
X.
Xxxxxxx Xxxxxx III
Title:
President and CEO
7
IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first
above written.
COUNTER
PART SIGNATURE PAGE TO STOCK ACQUISITION AGREEMENT
SELLLERS:
___________________________________
Print
Name Above
___________________________________
Signature
Name:
Xxxxxxx X. Xxxxxxxx, an individual
8
IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first
above written.
COUNTER
PART SIGNATURE PAGE TO STOCK ACQUISITION AGREEMENT
SELLLERS:
___________________________________
Print
Name Above
___________________________________
Signature
Name:
Xxxx X. Xxxxxx, an individual
9
IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first
above written.
COUNTER
PART SIGNATURE PAGE TO STOCK ACQUISITION AGREEMENT
SELLLERS:
___________________________________
Print
Name Above
___________________________________
Signature
Name:
Xxxxx X. Xxxxxxxxx
Title:
Trustee under Trust Agreement,
dated
July 3, 1990
___________________________________
Print
Name Above
___________________________________
Signature
Name:
Xxxxx X. Xxxxxxxxx
Title:
Trustee under Trust Agreement,
dated
July 3, 1990
10
IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first
above written.
COUNTER
PART SIGNATURE PAGE TO STOCK ACQUISITION AGREEMENT
SELLLERS:
___________________________________
Print
Name Above
___________________________________
Signature
Name:
Xxxxxx X. Xxxxx, an individual
11
IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first
above written.
COUNTER
PART SIGNATURE PAGE TO STOCK ACQUISITION AGREEMENT
SELLLERS:
___________________________________
Print
Name Above
___________________________________
Signature
Name:
Xxxxxx Xxxxx
Title:
Trustee of the Xxxxx Grandchildren’s Trust
Under
the
Xxxxxx Xxxx Xxxxx Revocable Trust,
Established
December 21, 1987
12
IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first
above written.
COUNTER
PART SIGNATURE PAGE TO STOCK ACQUISITION AGREEMENT
SELLLERS:
___________________________________
Print
Name Above
___________________________________
Signature
Name:
Xxxxxxx Xxxxxxxx
Title:
Trustee of the Xxxxxxxx Grandchildren’s Trust
Under
the
Xxxxxx Xxxx Xxxxx Revocable Trust,
Established
December 21, 1987
13
IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first
above written.
COUNTER
PART SIGNATURE PAGE TO STOCK ACQUISITION AGREEMENT
SELLLERS:
___________________________________
Print
Name Above
___________________________________
Signature
Name:
Xxxxxx Xxx Xxxxx Xxxxx
Title:
Trustee of the Yorke Grandchildren’s Trust
Under
the
Xxxxxx Xxxx Xxxxx Revocable Trust,
Established
December 21, 1987
14
SCHEDULE
“B”
DEFINITIONS
"Claim"
means
any claim, lawsuit, demand, suit, hearing, governmental investigation, notice
of
a violation, litigation, proceeding, arbitration, or other dispute, including
audits, investigations or claims for or relating to any liability in respect
of
taxes, whether civil, criminal, administrative or otherwise.
“Closing”
means
the mutual execution of this Agreement.
"including"
means
"including but not limited to" unless the context requires
otherwise.
“Indemnified
Party”
means
a
party seeking indemnification hereunder.
“Indemnifying
Party”
means
a
party from whom indemnification is sought hereunder.
"Lien"
means
any security interest, claim, lien, charge, mortgage, deed, assignment, pledge,
hypothecation, encumbrance, easement, or restriction of any kind or
nature.
"Losses"
means
any and all costs and expenses (including attorneys' fees and court costs
incident to any Claim), damages, judgments, assessments and losses, net of
any
tax adjustments, settlements, reductions or other effects which actually result
from the Loss and its payment by the party seeking indemnification.
"Person"
includes
any individual, sole proprietorship, partnership, joint venture, trust
incorporated organization, association, corporation, limited liability company,
institution, party, entity or governmental authority.
15
SCHEDULE
“C”
FORM
OF PROMISSORY NOTE
16
SCHEDULES
2.3
- On May 17, 2006, a $300,000
cash distribution to the CDC shareholders was authorized by Xx. Xxx Xxxxxxxx
on
behalf of the deal sponsor group for the purpose of covering the personal income
taxes of the CDC shareholders for 2005 undistributed earnings.
In
July
2006, a $1,000,000 cash distribution to the CDC shareholders was authorized
by
Xx. Xxx Xxxxxxxx on behalf of the deal sponsor group; this distribution
decreased the cash purchase price from $5 million to $4 million.
17